About
Royalmount laboratories
Our Progression
Our parent company Pharmascience Inc. has developed strong roots in Canada, and is Quebec’s largest employer in the pharmaceutical field with over 1500 employees.
Royalmount Labs external CRO business has become very successful, excelling in scientific excellence, customer service and on-time delivery. To accommodate the rapid growth, we continue to invest in the right staff, in the expansion and modernization of our laboratories, as well as in the latest technologies.
Where We Are Now
Pharmascience Inc. is currently Canada’s third largest generic pharmaceutical company.
Royalmount Labs now employs over 45 scientific, technical and support staff, and occupies 8000 sq ft of purpose built laboratory and office space. We have the latest state-of-the-art instrumentation including 13 LC-MS/MSs, 2 multimode spectrophotometer plate readers, a Luminex and 2 robotic liquid handling systems.
As a partner of choice for many pharma, biotech and virtual companies, we have a very high rate of repeat business, and this is a testament to our three core principles that we consistently deliver on to our clientele – Scientific Excellence; Customer Service; On-time Delivery.
Where We’re Going
Royalmount Labs has aggressive growth plans for the next several years, including introducing new service offerings.
In 2023, amongst other things, we established large molecule bioanalytical and biomarker services, as well as implemented the Watson Laboratory Information Management System (LIMS).
We aim to become the leading niche small and large molecule bioanalytical CRO.
Quality, always on time
Study-based inspections (study plan, in-process, study data and report for every study and validation); additionally perform regular facility-based and process-based inspections.
Strict adherence to Health Canada, EMA, and US FDA guidelines, ensuring the highest-quality procedures, data and reports.
Quality Assurance / Compliance Internal Auditors functions as an independent Quality Assurance Unit.
Quality Control / Data Review Team reviews 100% of raw data generated in the bioanalytical laboratories.
- FDA audits in 2018 (onsite) and 2022 (virtual); no FDA 483 issued
- GLP certified by Standards Council of Canada (SCC) since 2015; most recent re-certification in 2023
- GCP inspected by Health Canada in 2018
- GMP inspected by Health Canada in 2020, 2022 and 2024.
Regulatory Agencies
OUR FACILITIES
Our Montreal based GLP/GMP/GCP-compliant laboratories act as a key partner for numerous pharmaceutical and biotechnology companies. We adapt to the rapidly changing needs of our clients, overcoming the challenges related to regulated bioanalysis.
- Over 45 dedicated professionals
- 13 triple quadrupole mass specs including API 6500+ and 5000™
- 250,000 bioanalytical samples analyzed per year
- >300 validated assays available; extensive method development capabilities
- 1 Shimadzu ICP-MS
- 2 Shimadzu GC-MS/MS
- 2 Shimadzu HPLC-UV
- 1 qPCR
- 2 Agilent microplate spectrophotometer readers
- 1 Luminex
- 2 Hamilton® STAR™
Our team
Adrien has over 25 years of experience in the management of analytical and bioanalytical laboratory operations. Having joined Pharmascience in 2010, Adrien has executive responsibilities for Royalmount Laboratories. Adrien has a Doctor of Science degree in chemistry from the University of Antwerp in Belgium.
Alan has over 35 years’ experience in the CRO industry (including providing consulting services extensively supporting Royalmount Laboratories), as well as executive positions at Caprion (now CellCarta), Citoxlab, and Charles River Laboratories. Alan is a Chartered Chemist, and Fellow of the Royal Society of Chemistry (UK).
With over 25 years’ regulated bioanalysis experience spanning from preclinical and clinical CROs to pharmaceutical companies, John, who led the bioanalytical laboratory operations at Pharmascience for 8 years, is now responsible for business development.
Weixing is an experienced scientist and leader of the bioanalytical method development team. With a master’s degree and PhD in chromatographic separation science and mass spectrometry, Weixing has been responsible for the development of over 400 quantitative mass spectrometry-based methods for the measurement of small molecules, metabolites and proteins in complex biological matrices.
Julien joined Pharmascience Royalmount Laboratories as a key player in the Large Molecule Bioanalysis and Biomarkers group. He has extensive experience in PK/TK bioanalytical programs, including bioanalysis of biologics, oligotherapeutics and biomarkers, as well as immunogenicity testing. Julien, who has a master’s degree in Biochemistry, is also certified by the Microbiologists Association of Quebec and is a registered member of the Canadian College of Microbiologists.
Babak has over 18 years of experience in pharmaceutical bioanalysis. Having joined Pharmascience in 2016, Babak is currently responsible for acting as a scientific liaison between clients and operations, facilitating communication, collaboration and exchange of information and data. Babak has a master’s degree in organic chemistry.
Hong, who has extensive PK/TK reporting experience, has held positions as Senior PK/PD Scientist at Algorithme Pharma, and Charles River Laboratories, as well as Scientific/Technology Consultant for several investment firms. Prior to this, Hong was PK Scientist for Pharmanet Development Group (Syneos) and Senior Research Associate for the Cancer Therapy & Research Centre. Hong received his undergraduate training in Biochemistry, completed an MSc in Physiology, and received an MBA from the University of Laval.
Ying, who joined Pharmascience in 2016, is currently responsible for Nitrosamine impurities analysis by LC-MS/MS, and elemental testing by ICP-MS. Ying has over 20 years’ of experience working in the chemistry field under GLP and GMP regulated environments. Ying has a MSc degree in chemistry, and she is also a Registered Quality Assurance Professional in Good Laboratory Practice (RQAP-GLP).
With over 23 years of experience in regulated bioanalysis, Giuseppina has been with Pharmascience since 2008. As the Biopharmaceutics Quality Services Manager, she has overall responsibility for QA functions that assure GLP/ GCP/ GMP compliance.
With over 30 years of experience in bioanalysis, including 23 years in CRO preclinical and clinical bioanalysis, Samantha joined Pharmascience Royalmount Labs to oversee the LC-MS/MS Bioanalytical Operations. Samantha has a bachelor’s degree with honors in Pharmaceutical Sciences.